Bridgeway Capital Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-156,300
| Closed | -$494K | – | 1418 |
|
|
2023
Q3 | $494K | Hold |
156,300
| – | – | 0.01% | 873 |
|
|
2023
Q2 | $103K | Hold |
156,300
| – | – | ﹤0.01% | 1250 |
|
|
2023
Q1 | $125K | Buy |
156,300
+51,431
| +49% | +$41K | ﹤0.01% | 1197 |
|
|
2022
Q4 | $237K | Sell |
104,869
-35,000
| -25% | -$79.1K | 0.01% | 1048 |
|
|
2022
Q3 | $270K | Buy |
139,869
+69,060
| +98% | +$133K | 0.01% | 1071 |
|
|
2022
Q2 | $263K | Buy |
+70,809
| New | +$263K | 0.01% | 1031 |
|